Symposium Speaker: Patrick Raber, PhD

Patrick Raber, PhD

Dr. Patrick Raber is a scientific liaison with Adaptive Biotechnologies, a biotechnology company based in Seattle, Washington that specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Previous to his position at Adaptive, Patrick earned his PhD in the Department of Microbiology, Immunology, at Parasitology at LSU Health Sciences Center New Orleans. Based in Atlanta, Georgia, Patrick serves as scientific expert for applications of Adaptive’s immunosequencing platform including oncology, immunotherapy, transplantation, infectious diseases, and autoimmunity.  Patrick also assists investigators interested in incorporating Adaptive’s technology into clinical trials and research protocols.  

PUBLICATIONS ON ADAPTIVE BIOTECHNOLOGIES IMMUNOSEQ

DeWitt WS, et al. A Public Database of Memory and Naive B-Cell Receptor Sequences. PLoS One 2016. PMID:27513338

Howie B, et al. High-throughput pairing of T-cell receptor alpha and beta sequences. Sci Transl Med 2016. PMID:26290413

Tweets by Adaptive Biotechnologies

The technology to measure T cells with precision and at scale exists. A more complete understanding of the immune response to SARS-CoV-2 including both T cells and antibodies could offer insights to inform public health interventions. scientificamerican.com/article/what-d…

Welcome all 2022 Adaptive interns! We’re excited to have you join the team and look forward to the next few months together.

test Twitter Media - Welcome all 2022 Adaptive interns! We’re excited to have you join the team and look forward to the next few months together. https://t.co/3l7nwbD4qi

Join us at @DDWMeeting May 21-24 to hear from researchers utilizing immunoSEQ® to observe the humoral and cellular response to SARS-CoV-2 mRNA vaccination in patients with IBD. More info: adaptivebio.tech/7a9 For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - Join us at @DDWMeeting May 21-24 to hear from researchers utilizing immunoSEQ® to observe the humoral and cellular response to SARS-CoV-2 mRNA vaccination in patients with IBD. More info: https://t.co/wo2kjqVY9F

For Research Use Only. Not for use in diagnostic procedures. https://t.co/qSbteWxZNZ

.@MatthieuAllez will present data at @DDWMeeting demonstrating immunoSEQ® identified T-cell receptors linked to Crohn’s Disease from blood samples. Saturday, May 21st from 10:00am-10:15am PDT. adaptivebio.tech/7a9 For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - .@MatthieuAllez will present data at @DDWMeeting demonstrating immunoSEQ®  identified T-cell receptors linked to Crohn’s Disease from blood samples. Saturday, May 21st from 10:00am-10:15am PDT. https://t.co/wo2kjqEmL5

For Research Use Only. Not for use in diagnostic procedures. https://t.co/7bQHDRAOWV

What’s it like to be an intern at Adaptive? Sydney reflects on her experience and shares advice to all 2022 Adaptive interns. adaptivebio.tech/jom

test Twitter Media - What’s it like to be an intern at Adaptive? Sydney reflects on her experience and shares advice to all 2022 Adaptive interns. https://t.co/8WGtrDFRCy https://t.co/HQuNTXESr1

Meet Vita! Originally from Ukraine, she’s an Executive Assistant to the President and Manager of our NYC Office. Fun facts: she’s bilingual and when she isn’t working, she unwinds by reading and going on walks with her dog. #HumansOfAdaptive

test Twitter Media - Meet Vita! Originally from Ukraine, she’s an Executive Assistant to the President and Manager of our NYC Office. Fun facts: she’s bilingual and when she isn’t working, she unwinds by reading and going on walks with her dog. #HumansOfAdaptive https://t.co/RZVnvcbDtR

New publication @JCI_Insight: Data confirms T cells play a central role in mounting an immune response against SARS-CoV-2 that can persist for at least 15 months. adaptivebio.tech/5e7

test Twitter Media - New publication @JCI_Insight: Data confirms T cells play a central role in mounting an immune response against SARS-CoV-2 that can persist for at least 15 months. https://t.co/dDr0ThANo2 https://t.co/YWH5LEjdlt

MRD Chief Commercial Officer Nitin Sood discusses being on the patient’s side of the cancer journey and the profound influence it has in shaping his career path. adaptivebio.tech/k9a

test Twitter Media - MRD Chief Commercial Officer Nitin Sood discusses being on the patient’s side of the cancer journey and the profound influence it has in shaping his career path. https://t.co/deDK5awMOP https://t.co/eIHdVrOHvF

Thank you to each member of our Seattle and South San Francisco lab and lab support teams. This is a time to celebrate the important and essential work you do and express our collective appreciation. #LaboratoryProfessionalsWeek #LabWeek2022

test Twitter Media - Thank you to each member of our Seattle and South San Francisco lab and lab support teams. This is a time to celebrate the important and essential work you do and express our collective appreciation.  

#LaboratoryProfessionalsWeek #LabWeek2022 https://t.co/lkkL35EFyV

Explore the principles of our immune medicine platform and its potential application to the field of adoptive cell therapy in our upcoming webinar. adaptivebio.tech/7zi For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - Explore the principles of our immune medicine platform and its potential application to the field of adoptive cell therapy in our upcoming webinar. https://t.co/9c7GdqFvSr

 For Research Use Only. Not for use in diagnostic procedures. https://t.co/Q7oOLUjZ3W

It’s Medical Laboratory Professionals Appreciation Week! Our laboratory operations team is the heartbeat of Adaptive. Today and every day, we thank you for your ongoing dedication and persistence to improve the lives of patients. #LabWeek2022

Chief Operating Officer Mark Adams will share an overview of Adaptive’s Diagnostics business at this year’s Life Science Innovation Northwest 2022 conference. Join him on Wednesday, April 20th at 10am-12pm PT. Full agenda and registration here: adaptivebio.tech/hx3

test Twitter Media - Chief Operating Officer Mark Adams will share an overview of Adaptive’s Diagnostics business at this year’s Life Science Innovation Northwest 2022 conference. Join him on Wednesday, April 20th at 10am-12pm PT. Full agenda and registration here: https://t.co/LmLkRsAN3c https://t.co/e0NfycHa1S

Join Patrick Raber at World Vaccine Congress (@vaccinenation) where he will be discussing T-cell immune response, themes in vaccine development, and COVID-19 variants. Wednesday, April 20th at 3:40pm ET. Click here for the full agenda: adaptivebio.tech/1uw

test Twitter Media - Join Patrick Raber at World Vaccine Congress (@vaccinenation) where he will be discussing T-cell immune response, themes in vaccine development, and COVID-19 variants. Wednesday, April 20th at 3:40pm ET. Click here for the full agenda: https://t.co/oMbj9A99hk https://t.co/7Ra6rNpIMF

Join @sbenzeno, @SetteLab, @vaccinesguy07, @levy_o and Rafick-Pierre Sékaly for a @vaccinenation panel discussion on Immune Profiling: Lessons learned from the coronavirus pandemic to help inform future vaccine development. 4/20 at 9:10am ET. Agenda: adaptivebio.tech/1uw

test Twitter Media - Join @sbenzeno, @SetteLab, @vaccinesguy07, @levy_o and Rafick-Pierre Sékaly for a @vaccinenation panel discussion on Immune Profiling: Lessons learned from the coronavirus pandemic to help inform future vaccine development. 4/20 at 9:10am ET. Agenda: https://t.co/oMbj9A99hk https://t.co/KqIRKoJD74

Adaptive is hosting a symposium at #AACR22 with presentations on how the immunoSEQ Technology is uniquely suited to help answer questions related to immuno-oncology. Visit us at Booth 2210. adaptivebio.tech/6uy For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - Adaptive is hosting a symposium at #AACR22 with presentations on how the immunoSEQ Technology is uniquely suited to help answer questions related to immuno-oncology. Visit us at Booth 2210. https://t.co/bP5D9yjrxa  

For Research Use Only. Not for use in diagnostic procedures. https://t.co/jHsJ1jUQgb

Leadership. Mentorship. Growth. To power the age of immune medicine, we empower each other. Adapters share why mentorship is more important than ever. #WomensHistoryMonth

We recently spoke with Women in Immune Science (WISE) award winner, Ana Bolivar (@AnaMBolivarA), a PhD candidate in Dr. Vilar’s lab at the University of Texas @MDAndersonNews. Ana shared her research and hope for the future with us. Read the interview: adaptivebio.tech/0kw

test Twitter Media - We recently spoke with Women in Immune Science (WISE) award winner, Ana Bolivar (@AnaMBolivarA), a PhD candidate in Dr. Vilar’s lab at the University of Texas @MDAndersonNews. Ana shared her research and hope for the future with us. Read the interview: https://t.co/1FttGbduFn https://t.co/SoU6Kqkl0Q

More extensive deployment of existing methods for measuring T-cell immunity to SARS-CoV-2 could provide a more complete profile of the immune status for at risk populations and offer insights for informing public health interventions. Read @SciImmunology: adaptivebio.tech/zye

test Twitter Media - More extensive deployment of existing methods for measuring T-cell immunity to SARS-CoV-2 could provide a more complete profile of the immune status for at risk populations and offer insights for informing public health interventions. Read @SciImmunology:  https://t.co/VNg5dxiKZl https://t.co/5W3rUcufHF

Don’t miss leaders from @FoundationATCG, @YaleGICancers, and @AdaptiveBiotech for a @MAPSmedaffairs workshop about increasing gender equity in advisory boards. This session will define observed gaps in gender equity and share practical tips. Learn more: adaptivebio.tech/ckl

test Twitter Media - Don’t miss leaders from @FoundationATCG, @YaleGICancers, and @AdaptiveBiotech for a @MAPSmedaffairs workshop about increasing gender equity in advisory boards. This session will define observed gaps in gender equity and share practical tips. Learn more: https://t.co/7nzA6AXOcy https://t.co/Ac9ierRTZr

Looking forward to my presentation at #IO360NYC! I’ll be sharing an overview of the @AdaptiveBiotech immune medicine platform and how it can help inform immune-based therapies. Hope to see you there! Full agenda at adaptivebio.tech/bzt. @conferenceforum #IO #ImmunoOncology Retweeted by Adaptive Biotech

Adaptive Biotechnologies Website